Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses
- 1 June 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (6), 409-419
- https://doi.org/10.1038/nrc820
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?Blood, 2002
- Primary melanoma tumour regression associated with an immune response to the tumour‐associated antigen melan‐A/MART‐1International Journal of Cancer, 2001
- T Cell Antigen Receptor Vaccines for Active Therapy of T Cell MalignanciesAnnals of the New York Academy of Sciences, 2001
- Kinetics of cytokine expression in melanoma metastases classifies immune responsivenessInternational Journal of Cancer, 2001
- CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon CancerAnnals of Surgical Oncology, 2001
- A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell deathCurrent Biology, 2001
- Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastasesCancer, 1999
- The cytokine microenvironment of human colon carcinoma: Lymphocyte expression of tumor necrosis factor-α and interleukin-4 predicts improved survivalCancer, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986